retinaldehyde and Atherosclerosis

retinaldehyde has been researched along with Atherosclerosis* in 1 studies

Other Studies

1 other study(ies) available for retinaldehyde and Atherosclerosis

Article	Year
Targeted therapy of atherosclerosis by pH-sensitive hyaluronic acid nanoparticles co-delivering all-trans retinal and rapamycin. Nanoscale, 2022, Jun-23, Volume: 14, Issue:24 Atherosclerosis, the leading cause of death in the elderly worldwide, is typically characterized by elevated reactive oxygen species (ROS) levels and a chronic inflammatory state at the arterial plaques. Herein, pH-sensitive nanoparticles (HR Topics: Animals; Apolipoproteins E; Atherosclerosis; Hyaluronic Acid; Hydrogen-Ion Concentration; Inflammation; Mice; Mice, Inbred C57BL; Nanoparticles; Plaque, Atherosclerotic; Reactive Oxygen Species; Retinaldehyde; Sirolimus	2022

Article

Year

Targeted therapy of atherosclerosis by pH-sensitive hyaluronic acid nanoparticles co-delivering all-trans retinal and rapamycin.

Nanoscale, 2022, Jun-23, Volume: 14, Issue:24

Atherosclerosis, the leading cause of death in the elderly worldwide, is typically characterized by elevated reactive oxygen species (ROS) levels and a chronic inflammatory state at the arterial plaques. Herein, pH-sensitive nanoparticles (HR

Topics: Animals; Apolipoproteins E; Atherosclerosis; Hyaluronic Acid; Hydrogen-Ion Concentration; Inflammation; Mice; Mice, Inbred C57BL; Nanoparticles; Plaque, Atherosclerotic; Reactive Oxygen Species; Retinaldehyde; Sirolimus

2022